Trials / Withdrawn
WithdrawnNCT04572217
Medications After Adolescent Bariatric Surgery
Medications After Adolescent Bariatric Surgery Protocol for Inadequate Weight Loss Following Sleeve Gastrectomy in Adolescents and Young Adults: A Pilot Feasibility Study
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Janey Pratt · Academic / Other
- Sex
- All
- Age
- 12 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the feasibility to assess practicality of early weight loss medication usage in adolescent patients post-VSG with inadequate weight loss. Participants who enroll in the study will be prescribed off-label use of weight loss medications for a period of up to 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topiramate | Topiramate (starting dose 25 mg daily, max dose 100 mg daily) |
| DRUG | Phentermine | Phentermine (starting dose 8 mg, max dose 16 mg) |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
- First posted
- 2020-10-01
- Last updated
- 2025-05-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04572217. Inclusion in this directory is not an endorsement.